KR20240070587A - 무혈청 현탁 배양에 적응된 hek293 세포주 및 이의 응용 - Google Patents

무혈청 현탁 배양에 적응된 hek293 세포주 및 이의 응용 Download PDF

Info

Publication number
KR20240070587A
KR20240070587A KR1020247012818A KR20247012818A KR20240070587A KR 20240070587 A KR20240070587 A KR 20240070587A KR 1020247012818 A KR1020247012818 A KR 1020247012818A KR 20247012818 A KR20247012818 A KR 20247012818A KR 20240070587 A KR20240070587 A KR 20240070587A
Authority
KR
South Korea
Prior art keywords
cells
cell
serum
medium
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247012818A
Other languages
English (en)
Korean (ko)
Inventor
옌 왕
시아오 판
롱나 딩
얼징 훼이
춘링 쉬안
Original Assignee
지앙수 젠스크립트 프로바이오 바이오테크 컴퍼니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지앙수 젠스크립트 프로바이오 바이오테크 컴퍼니 리미티드 filed Critical 지앙수 젠스크립트 프로바이오 바이오테크 컴퍼니 리미티드
Publication of KR20240070587A publication Critical patent/KR20240070587A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020247012818A 2021-10-12 2022-10-12 무혈청 현탁 배양에 적응된 hek293 세포주 및 이의 응용 Pending KR20240070587A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111190063.4 2021-10-12
CN202111190063 2021-10-12
PCT/CN2022/124873 WO2023061409A1 (zh) 2021-10-12 2022-10-12 适应无血清悬浮培养的hek293细胞株及其应用

Publications (1)

Publication Number Publication Date
KR20240070587A true KR20240070587A (ko) 2024-05-21

Family

ID=85987273

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247012818A Pending KR20240070587A (ko) 2021-10-12 2022-10-12 무혈청 현탁 배양에 적응된 hek293 세포주 및 이의 응용

Country Status (6)

Country Link
US (1) US20240425880A1 (https=)
EP (1) EP4417689A4 (https=)
JP (1) JP2024538792A (https=)
KR (1) KR20240070587A (https=)
CN (1) CN118660958A (https=)
WO (1) WO2023061409A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121586778A (zh) * 2023-04-26 2026-02-27 赛诺菲 宿主细胞系以及用于鉴定和使用此类宿主细胞系的方法
CN117089514A (zh) * 2023-10-13 2023-11-21 思鹏生物科技(苏州)有限公司 提升hek293细胞系aav生产效率的细胞筛选驯化方法
CN117402817B (zh) * 2023-10-31 2024-09-27 山东丽山生物科技有限公司 一种无血清培养驯化贴壁293t细胞的方法及其应用
WO2025171001A1 (en) 2024-02-06 2025-08-14 Regeneron Pharmaceuticals, Inc. Compositions and methods for improved production of aav viral vectors
CN118222630B (zh) * 2024-05-23 2024-08-27 江西赛基生物技术有限公司 一种稳转表达cd16跨膜蛋白细胞系的构建方法及应用
CN119639654B (zh) * 2024-12-24 2025-10-31 华元(上海)生物医药有限公司 一种人胚胎肾单克隆细胞株及其在生产慢病毒载体中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140315294A1 (en) * 2011-11-24 2014-10-23 Genethon Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
CN102604889B (zh) * 2012-03-19 2013-05-08 中国农业科学院哈尔滨兽医研究所 适应无血清培养的hek293细胞系及其应用
EP2970920B1 (en) * 2013-03-15 2018-04-25 The Children's Hospital of Philadelphia Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system
CN104450607B (zh) * 2014-11-14 2017-07-11 武汉金开瑞生物工程有限公司 用于hek293细胞悬浮生长的全化学成分培养基及培养方法
CN110713971B (zh) * 2019-11-06 2021-08-27 深圳市菲鹏生物治疗股份有限公司 一种无血清悬浮培养型293t细胞、其制备方法以及病毒的包装方法
EP4273236A4 (en) * 2020-12-29 2025-01-08 Jiangsu Genscript Probio Biotech Co., Ltd. HEK293T CELL STRAIN WITH HIGH DISPERSIBILITY AND SCREENING METHODS THEREFOR

Also Published As

Publication number Publication date
US20240425880A1 (en) 2024-12-26
WO2023061409A1 (zh) 2023-04-20
EP4417689A1 (en) 2024-08-21
JP2024538792A (ja) 2024-10-23
CN118660958A (zh) 2024-09-17
EP4417689A4 (en) 2025-10-15

Similar Documents

Publication Publication Date Title
AU2023200992B2 (en) Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use
EP4417689A1 (en) Hek293 cell line adapted to serum-free suspension culture and use thereof
KR20250030036A (ko) 개선된 세포 트랜스펙션 및/또는 rAAV 벡터 생산을 위한 증진제
CN104520421A (zh) 用于生产腺伴随病毒的细胞系
JP7846625B2 (ja) 組換えａａｖの産生
WO2011097447A2 (en) Production of recombinant virus
EP4273236A1 (en) Hek293t cell strain having high dispersibility and screening method therefor
US20240279682A1 (en) AAV Manufacturing Methods
JP2026511015A (ja) 組換えａａｖ粒子調製物の生成のための方法
WO2026020116A1 (en) Methods and compositions for enriching the production of dna cargo loaded recombinant adeno-associated virus capsids
JP2025519228A (ja) 組換えａａｖ粒子を生成するための方法
HK40117756A (zh) 用於生产重组aav颗粒的方法
HK40117143A (zh) 用於生产重组aav颗粒的方法
EP4671265A1 (en) GENETIC CONSTRUCTIONS FOR ENHANCED AAV TITLES AND ASSOCIATED USEFUL POWER
HK40081423A (en) Recombinant aav production

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240417

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application